Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
Bio-IT World 
No comment yet.
Sign up to comment
Scoop.it!
The Swiss chemical and pharmaceutical industry – accounts for over 4 % of Gross Domestic Product and is the second most important industry, behind the engineering industry for the swiss economy. Good overview of the companies pharma industry.
Scoop.it!
BioPortfolio.com - the life science and healthcare portal BioPortfolio brings our visitors continuously updated biotechnology, pharmaceutical and healthcare n...
|
Scoop.it!
The Pharmaceutical industry continues to adopt simulation technologies for drug discovery and development. This week Simulations Plus, Inc., a provider of simulation and modeling software announced it had signed a collaboration agreement with a major pharmaceutical company to add a transdermal and subcutaneous dosing model within its GastroPlus simulation software program. GastroPlus™ is a mechanistic, physiologically-based simulation program that predicts the absorption, pharmacokinetics, and pharmacodynamics for drugs given through oral, intravenous, ocular or pulmonary routes.The funded collaboration enable Simulations Plus to extend the competitive advantage of GastroPlus without the need for Simulations Plus to fund the development directly.
Scoop.it!
Swiss pharmaceutical company Roche, with over SFr9.5 billion ($10.35 billion) in profits for 2011, is looking to secure its future and betting on personalised medicine in the process.
|
Transcriptic is an awesomely promising start up - that aims to provide automated execution of different lab protocols. Intersting article at Bio-IT World. If you are interested in the future of weblab work and how it connects to synthetic biology and bio discovery - well worth reading.